hgf plasmid
Gene therapyexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Apr 1, 2003 (NCT00060892)
Timeline
Indications
Mechanism of action
- Hepatocyte growth factorSupplementation
HGF supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hgf plasmid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02144610 | Phase 3 | Oct 1, 2014 | AnGes, Inc., Dartmouth University |
| NCT02016755 | Phase 2 | Nov 1, 2013 | AnGes, Inc., Dartmouth University |
| NCT00189540 | Phase 2 | Aug 1, 2005 | AnGes, Inc., Dartmouth University |
| NCT00060892 | Phase 2 | Apr 1, 2003 | AnGes, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AnGes, Inc. | For profit | 4 | 4 | 2 | 2003 |
| Dartmouth University | Academic/Hospital | 3 | 0 | 2 | 2005 |
2 organizations
Page 1 / 1